Accelerate Your Speed To Market Through Solid State And Crystallization Development

Employing crystallization holds the potential to provide tremendous efficiency in drug development and manufacturing, reducing costs in the process. Many chemical processes rely on chromatography for purification, but this can result in poor yields, expensive solvents, and lengthy unit operations. Crystallization is typically high yielding and, when optimized for the correct shape, can reduce filtration timelines.

While crystallization does require a robust control strategy to determine purity of intermediates/final API, the impact on bioavailability of the compound and downstream processability can help improve product efficacy and speed to market.

Learn more about the benefits and advantages of early solid state crystallization developments. Join Thermo Fisher Scientific experts Stephen Boppart, Director of Business Management, API, and Matthew Jones, Senior Manager Of Crystallization, Linz as they explain how to:

• Secure the benefits of well-timed and phase appropriate solid state and crystallization
• Accelerate development and reduce time-to-market by selecting the right form
• Improve decision making by collecting the accurate information in early development
• Avoid common mistakes with an experienced partner to support the development of a scalable crystallization and formulation processes